NCT03998033View on ClinicalTrials.gov

Study of ET140202 T Cells in Adults With Advanced Hepatocellular Carcinoma

PHASE1TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

May 30, 2019

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Hepatocellular CarcinomaLiver CancerLiver NeoplasmMetastatic Liver Cancer
Interventions
BIOLOGICAL

ET140202 autologous T cell product

Autologous T cells transduced with lentivirus encoding an ET140202 expression construct

Trial Locations (3)

91010

City of Hope Medical Center, Duarte

92697

UC Irvine, Irvine

95817

UC Davis, Sacramento

Sponsors
All Listed Sponsors
lead

Eureka Therapeutics Inc.

INDUSTRY

NCT03998033 - Study of ET140202 T Cells in Adults With Advanced Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter